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ABSTRACT 
Thyroid Hormones (TH) regulate myriad processes, such as development, metabolism and 
cardiovascular functions, by controlling gene expression through binding to nuclear thyroid 
hormone receptors, TRα and TRβ. While patients with mutations in the TRβ gene are well 
known, patients with TRα mutations have only recently been identified. To determine 
potential phenotypes of such patients, our lab previously created a mutant mouse line (TRα 
1+/m), in which the receptor affinity to TH is reduced. TRα1+/m mice display a wide range 
of abnormalities including hypermetabolism and mild bradycardia, contrary to what was 
predicted from receptor-mediated hypothyroidism. The aim of this thesis is to analyze the 
unexpected metabolic and cardiac phenotype in greater detail. Furthermore, it aims to 
elucidate the physiological phenotype of offspring from TRα1 mutant mothers.  
Hepatic glycogen content serves as a readout of the metabolic status of mammals. In paper I 
we show that hypermetabolism leads to completely depleted glycogen storage in adult TRα1 
mutants. Furthermore we show that the livers of these mice compensate for this loss by up-
regulating glucose production over glucose degradation, in contrast to what is observed in 
T3-treated animals, thus raising the possibility that additional TR-mediated regulatory 
mechanisms are at play. Remarkably, exposure to high maternal thyroid hormone fully 
restored glycogen levels in the TRα1+/m adult mice, demonstrating that genetic and maternal 
factors orchestrate the glycogen set point of the embryo.  
Studies from our lab showed that cardiomyocytes isolated from the TRα1+/m mice exhibit 
signs of severe hypothyroidism. Surprisingly, TRα1+/m animals are only slightly bradycardic 
despite a striking reduction in expression of the pacemaker gene, Hcn2, which in itself can 
induce a marked reduction of heart rate, paper II. We show that the autonomic regulation of 
heart rate in TRα1+/m mice fails to switch from sympathetic to parasympathetic tone in 
response to environmental stimuli such as temperature. In paper III, we find that impaired 
thyroid hormone signaling during development leads to an irreversible reduction in 
parvalbumin cell number in the hypothalamus, and that these cells regulate blood pressure 
and temperature-dependent changes in the heart rate. These data reveal a novel link between 
thyroid hormones and central regulation of the cardiovascular system. 
Recent studies suggest that maternal factors during pregnancy, such as hormones and 
nutrients, epigenetically affect the development of the embryo, with long-lasting effects on 
offspring metabolism and behavior. In paper IV we show that TRα1+/m mutant dams 
produce male wild type offspring that have a metabolically favorable outcome characterized 
by their decreased body fat mass, increased lean mass and elevated glucose utilization. 
However, these mice display an increased voluntary wheel-running behavior, reminiscent of 
animal models of Attention Deficit Hyperactivity Disorder and addictive behavior. We 
provide evidence that a likely cause of this phenotype is decreased expression of genes 
involved in regulation of reward circuits and that at least one of these genes is epigenetically 
regulated. Moreover, we show that the phenotype is transmitted to the second generation, 
through the paternal line.  
In conclusion, we show that proper thyroid hormone signaling is important during 
development to i) program the glycogen set point of the embryo; ii) regulate development of 
a novel hypothalamic cell population that controls cardiovascular functions; and iii) 
epigenetically regulate gene expression in the wild type embryo with long-lasting 
consequence for metabolism and behavior. 
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1 GENERAL INTRODUCTION 
Thyroid Hormones (TH) are required for development and proper functioning of a variety 
of organs and tissues in the body, beginning in the embryo, in which they play critical roles 
in metabolism and brain development. As will be discussed below, minor disturbances in 
TH signaling during this period can lead to altered metabolic tone, increasing the risk of 
developing metabolic and cardiovascular diseases as adults. In cases of severe TH 
deficiencies, even more deleterious and irreversible defects such as mental retardation and 
growth abnormalities can arise. This thesis addresses the effects of maternal receptor-
mediated hypothyroidism on the developing embryo.  
1.1 Thyroid Hormone production and release 
THs are produced by follicular cells of the thyroid gland situated in front of the trachea, and 
exist in two forms: 3, 3,`5, -triiodothyronine and 3, 3`,5, 5`- tetraiodothyronine, or T3 and T4, 
respectively. The production and secretion of THs is regulated by a negative-feedback 
mechanism that involves the hypothalamic-pituitary-thyroid (HPT) axis. Thyrotropin-
releasing hormone (TRH) released from the hypothalamus stimulates the pituitary to produce 
and release the thyroid-stimulating hormone (TSH), which in turn stimulates the thyroid 
gland to release T4 and T3 into the circulation. THs exert negative feedback control on both 
TSH and TRH (Figure 1).  
 
 Figure 1. The HPT axis. TRH and TSH stimulate T3 and T4 release, while their own release is 
inhibited by these hormones. (+), stimulation; (-), inhibition 
Although T4 is the most abundant form released by the thyroid, it binds to thyroid hormone 
receptors with weaker affinity than T3 and is therefore considered to be mainly a prohormone 
(Sandler et al., 2004). Most circulating TH is bound to plasma proteins such as thyroxin-
binding globulin (TBG), thyroxin binding prealbumin and human serum albumins. 
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Previously, it was thought that THs passively diffuses over the cell membrane. However, 
converging lines of evidence have culminated in a new paradigm, namely that THs are 
transported by cellular transmembrane transport mechanisms involving specific transporter 
proteins, e.g. organic anion transporting polypeptide OATP and monocarboxylate 
transporters such as MCT8. Once inside the cell, T4 is converted by enzymes called 
deiodinases that remove an iodine from the outer ring of the T4, thus generating the active 
form T3. This function is performed by type 1 and type 2 deiodinases (D1 and D2). When D1 
and D3 remove iodine from the inner ring, the hormone is inactivated (Figure 2) (Bianco et 
al., 2002).  
 
Figure 2. Different deiodinases regulate activation or inactivation of THs.   
1.2 Thyroid Hormone Receptors 
T3 exerts its action by binding Thyroid Hormone Receptors (TRs). These are transcription 
factors in the nuclear receptor superfamily and are encoded by two separate genes, THRA 
and THRB. Through alternative splicing, these give rise to mainly 4 different isoforms, 
TRα1/α2 and TRß1/ß2 (Figure 3). TRs contain a DNA-binding domain, which binds to 
Thyroid Hormone Response Elements (TREs) in the regulatory regions of target genes. TRs 
have been described to bind either as monomers or heterodimers, often together with the 
Retinoid X Receptor. TRα1 and both TRß isoforms bind T3 in their carboxy-terminal ligand-
binding domains. By contrast, although TRα2 binds weakly to TREs, it has a truncated 
ligand-binding domain and different carboxy terminal domain, and consequently cannot 
associate with the ligand; its function remains enigmatic (O'Shea and Williams, 2002). 
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Figure 3. Thyroid Hormone Receptor isoforms  
TRs are active also as aporeceptors, i.e. in the absence of ligand binding. Thus, target genes 
that are activated by ligand are repressed in its absence, and vice-versa, via recruitment of co-
repressors such as nuclear receptor co-repressor 1 (NCoR) and co-activators such as steroid 
receptor co-activator (SRC) respectively. Because of this, aporeceptor activity leads to more 
detrimental outcomes for the organism following loss of thyroid hormone than loss of its 
receptor (Flamant et al., 2002; Gothe et al., 1999; O'Shea and Williams, 2002). However, the 
mechanisms of gene repression are to date not fully understood. In general, ligand binding 
leads to a transcriptional switch in which co-repressor binding is destabilized and co-
activators are recruited in their place (Figure 4).  
 
Figure 4. Schematic representation of ligand induced positive regulation of target genes by TR.  
TR isoforms are expressed in almost all tissues with TRα1 being the most abundant isoform 
in the heart, brain and bone while TRß2 is found in hypothalamus, pituitary and auditory 
system. TRß1, meanwhile, is the predominantly expressed in liver and kidney (Brent, 1994).  
1.3 Disorders associated with Thyroid Hormone Signaling  
Given the wide distribution of TRs and TH-responsive genes, it is not surprising that 
disturbances in TH signaling can lead to deleterious effects.                                                                                       
Hyperthyroidism, i.e. excess of TH, is often caused by the autoimmune condition Graves 
disease, in which autoantibodies over-stimulate the thyroid gland to produce T4 and T3, 
leading to a range of symptoms such as hyperactivity, tachycardia, depression, weight loss 
and heat intolerance. Conversely, low levels of TH cause hypothyroidism. This common 
endocrine disorder is associated with symptoms such as depression, weight gain, cold 
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sensitivity and dry skin and can be caused by inflammation of the thyroid gland, iodine 
deficiency or the autoimmune disorder Hashimoto’s Thyroiditis, in which follicular cells of 
the thyroid are lost (Roberts and Ladenson, 2004). The causes of these autoimmune disorders 
are not clear but are believed to include genetic factors, age, gender, lifestyle choices and 
presence of other immune disorders. 
Congenital hypothyroidism (CH) is the most common endocrine disorder after diabetes, 
affecting 1 in 3500 infants (Kopp, 2002) and results in hypothyroidism from birth onwards. 
Today, all newborns are screened for this condition. If not treated within the first days after 
birth, CH leads to severe mental retardation and growth abnormalities. After iodine (essential 
component of TH synthesis) deficiency, the most common cause of CH is defective thyroid 
gland development, which is at least in some cases due to mutations in genes regulating 
thyroid gland development (Mansouri et al., 1998).  
Resistance to thyroid hormone ß (RTHß) is caused by mutations in the TRß gene that lead to 
reduced binding to T3 (Refetoff et al., 1993). Symptoms of RTHß include elevated serum 
levels of TH and TSH, goiter and tachycardia (Refetoff and Dumitrescu, 2007). Symptoms 
resulting from low or high TH action differ in different tissues, depending on which TR 
isoform is predominantly expressed. 
1.3.1 Mice with a mutation in the TRα1 gene (R438C) 
RTHß was first described in 1967 and since then around 3000 cases have been identified. 
However, until 2012, no naturally occurring mutations in the TRα1 gene had been found. 
This was explained by the possibility that such a mutation could be lethal or alternatively 
would not be characterized by the usual symptoms associated with disrupted thyroid hormone 
signaling. It was reasoned that an understanding of the role of TRα1 in mice might uncover 
previously unassociated symptoms of resistance to thyroid hormone, i.e. an RTHα phenotype. 
One such mutant mouse line, TRα1R438C, is the subject of this thesis.  
The amino acid substitution introduced into the ligand-binding domain of the TRα1 gene was 
originally identified in TRß of a RTH patient family. This mutation leads to a 10-fold reduced 
affinity for T3, allowing the mutant receptor to be reactivated by supraphysiological doses of 
T3. In utero, the receptor can be reactivated through exposure to high TH, either by treating 
the mother with T3 or by using TRß-/- mothers in which the negative feedback on TSH is 
disrupted, exposing the embryo to endogenously high TH throughout gestation. TRα1R438C 
mice, hereafter referred to as TRα1+/m mice, are euthyroid, i.e. have normal TH levels and 
normal to low TSH levels. The mice exhibit a plethora of abnormalities, including postnatal 
retardation in growth and development, high anxiety and cardiac abnormalities (the latter 
aspect is further discussed in Papers II and III). Furthermore, these animals display a striking 
metabolic phenotype such as hyperphagia, resistance to diet induced obesity and an increased 
basal metabolic rate, which consequently leads to a lean phenotype (Tinnikov et al., 2002; 
Venero et al., 2005; Wallis et al., 2008). Surprisingly, this resembles hyperthyroidism, as 
opposed to hypothyroidism, which would be predicted from a dominant mutation that leads 
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to a reduced affinity to T3. Further studies identified impairment in heat conservation and 
dissipation through the tail vein (Warner et al., 2013) which caused these animals to activate 
brown adipose tissue (BAT) via sympathetic stimulation, increasing the turnover of lipids and 
carbohydrates in several tissues, in particular BAT, in order to maintain heat. Moreover, 
hepatic glycogen was completely depleted to fuel this function of BAT in these animals, yet 
they remained euglycemic (further discussed in Paper I).  
1.3.2 Additional animal models with a mutation in the TRα1 gene  
Three additional mouse models harboring mutations in the TRα1 gene have been created 
(Kaneshige et al., 2001; Liu et al., 2003; Quignodon et al., 2007). The chosen mutations 
either reduced binding to T3 or abolished the binding completely. As expected, given the 
high distribution of TRα1 in neurons, bone and cardiac tissue, most of these strains display 
abnormalities in fetal and postnatal growth and development and exhibit a cardiac phenotype. 
None of the strains display high fluctuations in TH levels, however most of them show 
different levels of TSH that vary with age. A notable difference between these models is their 
metabolic phenotype. For example, the TRα1P398H mice are obese, arguing that the site of 
the mutation has high impact on the phenotype (Liu et al., 2003). Indeed, it was shown that 
this particular mutation interferes with Peroxisome proliferator-activated receptor alpha 
(PPARα) signaling and, consequently leading to abnormal gene regulation and obesity. 
1.3.3 RTHα in patients harboring mutations in the TRα gene 
In 2012, the first description of a patient with a mutation in the TRα1 gene was published, 
followed by identification of additional 10 patients, all diagnosed with the newly named 
RTHα (Bochukova et al., 2012; Moran et al., 2014; Moran et al., 2013; van Mullem et al., 
2012) (unpublished data).  In all cases, the HPT axis was not as clearly affected as in patients 
with previously characterized conditions associated with TH disturbances such as RTHβ. 
However, all patients displayed abnormalities in T3/T4 ratio, which is still the best 
biochemical marker. As expected from the animal models, these patients showed delayed 
bone development, impaired neuronal development and bradycardia. However, none of the 
patients displayed a lean phenotype as seen in our mice. One possible explanation for this 
discrepancy would be that the site of the mutation results in differential affinity for T3 and/or 
other transcription factors.  
1.4 Thyroid Hormone signaling during pregnancy 
Subclinical hypothyroidism (SCH), also referred to as mild thyroid failure, has an incidence 
of 2-3% among pregnant women (Lazarus et al., 2014). However, this number varies in 
different countries and can reach up to 13.7% as seen in Northern Spain (Aguayo et al., 
2013).  TSH levels higher than the upper limit for pregnancy- related reference range, 
together with normal T4 levels, characterize SCH. Disturbances in TH signaling during 
pregnancy have detrimental effects on the developing embryo, especially on the developing 
brain, in which TH promotes synaptogenesis, myelination and neuronal migration. 
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Importantly, fetal TH synthesis is only initiated around the beginning of the second trimester, 
so the offspring is completely dependent on the maternal supply prior to this time (de Escobar 
et al., 2007). However, the mother’s body faces its own challenges in maintaining 
euthyroidism, as the pregnancy itself sets a high demand on TH regulation: Firstly, chorionic 
gonadotropin hormone (hCG) secreted from placenta can mimic the TSH signal and thus lead 
to higher production of TH. Secondly, the pregnancy-associated increase in estrogen levels 
leads to higher TBG levels in the blood and hence reduced free T4 levels. The decreased 
negative feedback stimulates TSH secretion, which leads to increased secretion of TH to 
maintain normal TH levels. Thirdly, demand for iodine is increased during pregnancy, in 
response to (i) the body’s own demand for TH synthesis, (ii) increased iodine clearance by 
the kidney, and (iii) the demands of the fetus (Nathan and Sullivan, 2014). In developing 
countries, lack of iodine is the biggest cause of maternal hypothyroxinemia, which results in 
endemic cretinism in the offspring (de Escobar et al., 2007). This is a relatively common 
condition, characterized by severe mental retardation and growth defects. The World Health 
Organization (WHO) has estimated that 50 million people suffer from some degree of iodine 
deficiency-related damage, which can lead to lower performance on IQ tests and difficulties 
in everyday life. In 2011, the WHO estimated that 1.88 billion people worldwide have 
insufficient dietary iodine intake (Andersson et al., 2012). Considering the ease with which 
this type of maternal and fetal hypothyroidism can be reversed, simply through iodine 
supplementation, the WHO has issued an effort to address iodine deficiency in the 54 most 
affected countries. Screening for TH disturbances during pregnancy is still not routinely done 
anywhere in the world. In Sweden for example, pregnant women must specifically ask for a 
TSH/TH test at their first check-up, which is as late as around week 10-12 of pregnancy 
(http://www.1177.se/Stockholm/Tema/Gravid/). This could lead to severe damage to the 
embryo due to its absolute dependence on maternal TH prior to this time.  
Besides iodine intake, adequate nutritional status of the mother is also important for 
maintaining sufficient levels of selenium, which has an essential role for TH metabolism, 
firstly for deiodinase function and secondly for function of glutathione peroxidase, which 
metabolizes the H2O2 produced when iodine and tyrosine are coupled to form TH (Arthur, 
1991). Other adverse effects of low nutritional intake during pregnancy are reduced thyroid 
gland activity, TH synthesis, metabolism, and expression of TRs. In addition to causing 
neurological defects, this leads to impaired gene expression in peripheral tissues and 
consequently reduced tissue growth and metabolism (Dauncey et al., 2001). 
Maternal hyperthyroidism occurs in 0.4-1.7% of pregnant women and is mostly caused by 
gestational transient thyrotoxicosis, which in turn is triggered by elevated hCG levels (Nathan 
and Sullivan 2014). Another common cause is Graves disease.  Both conditions can lead to 
fetal thyrotoxicosis, which is characterized by fetal tachycardia, accelerated bone maturation 
and intrauterine growth retardation. The latter has adverse consequence for the offspring 
metabolism and behavior (Polak et al., 2004). Maternal hyperthyroidism can also lead to 
reduced thyroid gland and abnormalities in thyroid morphological characteristics in children, 
which can cause congenital hypothyroidism in those children (Dussault, 1993).  
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2 AIMS 
The subject of this thesis is to study effects of mutated TRα1 on liver metabolism (paper I), 
cardiac function (paper II and III) and offspring physiology (paper IV). TRα1+/m mice have 
been instrumental in the identification of patients harboring TRα1 mutations; as such 
mutations in mice are characterized by overlapping but distinct phenotypes, further analysis 
of the TRα1+/m model should help the search for new patients. Numerous studies have 
determined that hormones and nutrients from the pregnant mother affect the future 
metabolism and behavior of the unborn offspring. An analysis of the phenotype of offspring 
born to mothers with disruptive thyroid hormone signaling could therefore help identify any 
potential conditions these individuals might have, despite not having inherited the mutant 
allele. Specifically, the work comprising this thesis aims to: 
I) determine how the liver of the TRα1+/m mice is affected by hypermetabolism, 
and investigate a potential role of TRα1 signaling in glucose metabolism; 
 
II) understand how TRα1 signaling interacts with the autonomic control of heart rate; 
 
III) determine central effects of thyroid hormone on cardiovascular function; 
 
IV) understand how the wild type offspring of TRα1+/m females are affected. 
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3 EFFECTS OF THYROID HORMONE ON THE LIVER 
Previously it was shown that TRα1+/m mice display hypermetabolism due to sympathetic 
stimulation of BAT. In this study, we wanted to investigate i) how liver tissue responds to 
hypermetabolism and ii) a potential genetic interaction between mutant TRα1 and genes 
involved in glucose metabolism.  
3.1 The murine liver and Thyroid Hormones 
One of the many functions of the liver is to maintain glucose homeostasis in the body. This is 
accomplished by i) producing glucose to be transported in the blood to other organs such as 
BAT or ii) by degradation of glucose. 
Thyroid Hormones play important roles in regulating hepatic cholesterol and triglyceride 
metabolism, glycolysis and gluconeogenesis (Yen, 2001). Hypothyroid patients often develop 
non-alcoholic fatty liver disease, which is associated with obesity and/or type 2 diabetes. 
Many of the TH target genes in liver are down-regulated in hypothyroidism, leading to 
increased cholesterol and triglycerides. Conversely, in hyperthyroidism, excessive lipid 
oxidation can lead to tissue damage due to generation of reactive oxygen species, 
substantially increasing the risk of liver failure. TH also induces glucose-producing genes, 
such as phosphoenol-pyruvate kinase (PEPCK), the rate-limiting enzyme involved in 
gluconeogenesis, and represses pyruvate kinase (Pyrk), the rate-limiting enzyme in 
glycolysis. Consequently, hyperthyroidism increases and hypothyroidism decreases glucose 
production and utilization by peripheral tissues (Yen et al., 2003).                                         
TH function in the liver is mostly mediated by TRß, which regulates ~85% of TH-responsive 
genes, with TRα1 believed to regulate the balance (Flores-Morales et al., 2002).  
3.2 Consequence of mutant TRα1 on the liver (paper I) 
In paper I we found that TRα1+/m mice respond to hypermetabolism by increasing 
gluconeogenesis, which requires PEPCK, and decreasing glycolysis, which requires Pyrk. As 
T3 positively regulates PEPCK and suppresses Pyrk, this finding was unexpected, and the 
inverse of what was expected to occur in receptor-mediated hypothyroidism. We also found 
that the TRα1+/m mice have completely depleted glycogen storage, suggesting that the 
increased gluconeogenesis serves to replenish the depleted glycogen storage. Upon exposure 
of TRα1+/m embryos to high maternal thyroid hormone, in order to reactivate the mutant 
receptor in utero, the glycogen phenotype was reversed. The data suggest that the liver 
phenotype of the TRα1+/m mice is caused by a combination of defective TRα1 signaling in 
the liver, affecting the PEPCK and Pyrk expression, and hypermetabolism. Importantly, these 
results show that genetic and maternal factors interact to determine the metabolic set point in 
the offspring.  
In order to disassociate effects of T3 and metabolism, a desirable experiment would be to 
induce fetal hyperthyroidism as opposed to exposing the mother to T3, as this already 
impacts offspring metabolism. Nevertheless, a requirement for proper maternal TH during 
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fetal development for glycogen content has since been observed in sheep (Forhead et al., 
2009). In this study T3 levels were manipulated during mid to late gestation by a combination 
of T3 infusion in utero and fetal thyroidectomy. Induced hypothyroidism led to decreased 
glycogen content in adult sheep, while T3 infusion to embryos with intact thyroids caused an 
increase in hepatic glycogen. 
The precise mechanism of mutant TRα1 activity in glucose metabolism has yet to be 
determined. However, this would require the generation of a liver-specific TRα1+/m mutant. 
Lastly, it would be interesting to see whether the expression levels of the PEPCK and Pyrk 
are restored when TRα1+/m receptor is activated in utero, as this would demonstrate that the 
increased gluconeogenesis and decreased glycolysis serves as a compensatory mechanism to 
replenish the depleted glycogen stores and that expression of genes involved in these 
processes are dependent on proper TRα1+/m signaling in utero. 
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4 EFFECTS OF THYROID HORMONE ON CARDIAC 
MUSCLE 
TRα1+/m mice only display mild bradycardia despite the severe decrease in contractility of 
isolated cardiomyocytes. In the following studies we aimed to identify tissue-autonomous 
defects and to unravel mechanisms that mask the mild cardiac phenotype. 
4.1 The contractive cardiac muscle  
The function of the heart is to distribute blood to the body, which it does by the coordinated 
contraction of its cardiomyocytes (Rapila et al., 2008). Although cardiomyocytes, in contrast 
to skeletal and smooth muscle, are characterized by rhythmic contractility, the coordinated 
contraction of these cells is regulated by specialized cardiomyocytes, the cardiac pacemaker 
cells, that are only weakly contractile but produce electrical impulses that are propagated 
along the length of the myocardium. The heart consists of four chambers: the left atrium and 
left ventricle, which transport oxygenated blood to the body, and the right atrium and right 
ventricle, which transport de-oxygenated blood to the lungs. Each contraction cycle (heart 
beat) includes two major actions: (1) contraction of the atria causes blood that has moved into 
these chambers to pass into the ventricles, which (2) is then transported from the right 
ventricle to the pulmonary circulation, via the pulmonary artery and from the left ventricle to 
the systematic circulation, via the aorta (Young, 2010). 
Under normal resting conditions, the heart is not dependent on control from the nervous 
system or hormonal stimulation to contract, because of the pacemaker cells, which are located 
in the sinoatrial (SA) node on the right side of the heart, the atrioventricular (AV) node in the 
septum, and Purkinje fibers that branch throughout the ventricular wall (Young, 2010). The 
SA node, also known as the heart’s pacemaker, is located in the upper wall of the right 
atrium. Through spontaneous depolarization, i.e. a positive change in membrane potential, it 
initiates an action potential, leading to atrial contraction, or systole. The action potential 
reaches the AV node, situated in the lower right atrium, and leads to the ventricular systole. 
Following the atrial systole, the membrane potential of atrial myocytes returns to the resting 
state, or diastole, by hyperpolarization of the membrane potential. The coordination of these 
steps is essential to allow the chambers time to refill following their respective contractions. 
This regulation of contractility is mediated by different ion channels expressed on the cell and 
sarcoplasmic membranes of myocytes (Young, 2010).   
The velocity of the heart rate is also regulated by changes in the periphery, which are 
mediated by the autonomic nervous system (ANS) and hemodynamic changes. The 
autonomic nervous system controls visceral functions and is divided into 1) the 
parasympathetic nervous system, which controls bodily activities that occur at rest, e.g. 
respiratory rate and digestion, and 2) the sympathetic nervous system, which controls the 
“fight-or-flight” response (Hildreth et al., 2009).  
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The systemic circulatory system carries oxygenated blood from the heart to the rest of the 
body and returns deoxygenated blood back to the heart. The velocity of vascular circulation is 
dependent on the pressure exerted by blood on the wall of blood vessels. This in turn is 
dependent on the pressure generated by the heart. During each heart beat, arterial pressure is 
at its highest during the systole (contraction of the cardiac muscle) and at its lowest during the 
diastole (cardiac relaxation). Changes in arterial pressure and resistance lead to altered blood 
volume and consequently an altered cardiac response in order to maintain homeostasis.  
The heart is a major target organ for thyroid hormone (TH) action, and marked changes in 
cardiac function occur in patients with hyper-or hyporthyroidism (Kahaly and Dillmann, 
2005). The link between the thyroid gland and the heart was discovered in 1825 by C. Parry, 
who noticed the correlation between an enlarged thyroid area and palpitation, a typical 
symptom of hyperthyroidism (Kahaly and Dillmann, 2005). However, effects of 
hypothyroidism on cardiac performance remained unrecognized until 1918 when H. Zondek 
noted classical clinical features of hypothyroidism and found that these changes could be 
ameliorated by treating patients with thyroid extract (Kahaly and Dillmann, 2005).  
Today, we know that TH increases peripheral oxygen consumption, causing a secondary 
increase in cardiac contractility, as well as directly regulating cardiac contractility.  THs 
exerts its action on the myocardium by at least three different routes: 1) through direct gene 
regulation (further discussed in Paper II); 2) through the sympathetic nervous system (further 
discussed in paper II and III); and 3) through hemodynamic changes (further discussed in 
paper III) (Dillmann, 2002). 
4. 2 Thyroid Hormone action on the heart through direct gene regulation 
As described in section 1.2, TH exerts its effects by binding to Thyroid Hormone Receptors 
(TRs). TRs bind the TREs on target genes as holo- and aporeceptors and regulate the 
expression of these genes (Sap et al., 1986; Weinberger et al., 1986).   
T3 has been shown to shorten diastolic relaxation and hypothyroidism to prolong it in all 
mammalian species (Mintz et al., 1991). Decreasing the concentration of free calcium ions in 
the cytosol is the primary mechanism for myocyte relaxation, inhibiting the incorporation of 
calcium ions in troponin C, the thin filament of myofibrils (muscle fibers). Sarcoplasmic 
Reticulum Ca(2+) ATPase (SERCa2), the key calcium pump involved in regulating cytosolic 
calcium, is localized on the sarcoplasmic reticulum (SR), a membranous organelle 
surrounding the myofibrils. SERCa2 is strongly upregulated in response to T3, and three 
TREs have been found in the regulatory region of this gene (Hartong et al., 1994; Rohrer and 
Dillmann, 1988). T3 negatively regulates the expression and function of the SERCa2 
inhibitor phospholamban (Plb), thereby increasing the activity of SERCa2 protein as well 
(Kiss et al., 1994; Ojamaa et al., 2000). The expression of ryanodine channels that contribute 
to free cytosolic calcium in the SR is also increased by TH (Arai et al., 1991). The increased 
expression and activity of these channels underlies the increased heart rate that accompanies 
hyperthyroidism. At the end of the systole, the membrane potential of the myocytes returns to 
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the resting state by repolarization. This is achieved through opening of potassium channels 
and the resulting flow of K+ ions out of the cell. Several voltage-gated potassium channels 
are regulated by TH, e.g. KCNA5, KCND2, and KCND3, thus coordinating the 
electrochemical responses of the myocardium (Ojamaa et al., 1999). TH also regulates 
proteins directly related to mechanical contraction of the heart, such as Myosin heavy chain 
(MHC) isoforms. MHCa, which has high ATPase activity and contractile properties, is 
positively regulated by T3 and accelerates contraction of the hyperthyroid heart, whereas 
MHCb, which has low ATPase activity and contractile properties, is negatively regulated by 
TH, resulting in decreased velocity of contraction in hypothyroid heart (Morkin, 1993). 
Additionally, other components of the contractive machinery such as actin and troponin I are 
also positively regulated by TH (Dieckman and Solaro, 1990). TH also positively regulates 
the ion channel in the SA node, hyperpolarization cyclic nucleotide 2 (HCN2) that plays a 
pivotal role in cardiac pacemaker activity (Pachucki et al., 1999).  
4.3 Animal models of Thyroid Hormone Receptors and the cardiovascular phenotype  
Given the importance of direct regulation of cardiac genes by TH and its receptor, TR, 
several TR-deficient animal models have been generated. Wikström et al (1998) was the first 
to show that TRα1 plays a central role in the heart, as mice deficient of this receptor 
displayed bradycardia, accompanied with prolonged repolarisation. Further studies confirmed 
that TRα1 is the predominantly expressed isoform in the murine heart, accounting for 70% of 
total cardiac TR transcripts, with TRß1 contributing the remaining 30% (Gloss et al., 2001; 
Johansson et al., 1999).  
Mouse mutants lacking TRα are collectively referred to as TRαKO and include TRα1-/- and 
TRα0/0 (Gloss et al., 2001; Wikstrom et al., 1998). These mutants recapitulate the effects of 
hypothyroidism in the heart, displaying bradycardia that is accompanied by decreased levels 
of the Hcn2 and Hcn4 pacemaker genes. Expression of K+ channels involved in action 
potential repolarization is also decreased in TRαKO mice. Moreover, whereas the contractile 
machinery components such as SERCa2 and MHC-a are also markedly decreased in TRαKO 
mice, the negative regulator of contractility, MHC-b, is increased. By contrast, TRßKO 
animals recapitulate the effects of hyperthyroidism in the heart due to the derepression of Tsh 
that leads to higher TH levels acting on TRα1, and these mutants accordingly display 
tachycardia. Consistent with this, when TRßKO animals are made euthyroid, the heart tissue 
of these animals no longer shows significant electrophysiological or contractile changes, nor 
changes in the expression of corresponding genes such as HCN2/4 and SERCa2, supporting 
the evidence that these genes are targets of TRα (Gloss et al., 2001).  
T3 treatment of TRα1-/- mice leads to a partial rescue of the decreased heart rate, suggesting 
that TRß may compensate the effects of TH in the heart to a certain extent, given that TRα2 
cannot bind T3 (Wikstrom et al., 1998). However, in wild type mice, the TRß-selective 
agonist GC-1 does not enhance cardiac output to the same level as T3, underscoring that 
TRα1 is the predominant receptor through which TH exerts its effects on the heart (Trost et 
al., 2000).  
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4.3.1 The consequences of aporeceptor activity on gene expression and cardiac function 
As described in section 1.2, TRs act in the absence of ligands as aporeceptors to repress their 
target genes. For example, it has been shown that unliganded TRα1 represses Hcn2: Pax8-/- 
mice, which fail to produce TH, display normal expression of Hcn2 when crossed with 
TRα0/0 mutants, whereas in Pax8-/-;TRß-/- double  mutants, expression remains low due to 
repression by the unliganded TRα1 (Flamant et al., 2002). To analyze the TRα1 aporeceptor 
activity, four animal models have been created in which TRα1 affinity to T3 is either reduced 
or abolished, resulting in a dominant negative and receptor-mediated hypothyroidism. The 
three with reduced affinity to T3 or the co-activators exhibit bradycardia, whereas the fourth, 
in which affinity to T3 is abolished, shows no alteration (Kaneshige et al., 2001; Liu et al., 
2003; Quignodon et al., 2007; Tinnikov et al., 2002).   
4.3.2 Heart phenotype of the TRα1+/m mice  
Mice with a dominant-negative mutation of TRα1R384C (TRα1+/m mice) were generated in 
our lab (Tinnikov et al., 2002). As described in section 1.3.1, this mutation leads to a 10-fold 
reduced affinity to T3: consequently the receptor can be reactivated by supraphysiological 
levels of T3. Isolated cardiomyocytes from these animals fully recapitulated the hypothyroid 
phenotype with severely slowed contractions, a prolonged diastole and impairment of Ca2+ 
handling (Tavi et al., 2005). ß-adrenergic stimulation, which has previously been shown to 
result in phosphorylation of PLB and thereby increased SERCa2-dependent Ca2+ release and 
uptake (Koss and Kranias, 1996) resulted in a greater relative increase of contractility in the 
isolated mutant cardiomyocytes than in their wild type counterparts. However, even with ß-
adrenergic stimulation, the rates of Ca2+ decline and relaxation were not normalized. 
Moreover, despite the higher responsiveness to ß-adrenergic stimulation, injection of the mice 
with catecholamine isoprenalin failed to increase the heart rate of TRα1+/m mice to the same 
level as wild type mice (Tavi et al., 2005). In paper I, we measured Hcn2 expression by 
qPCR of mutant and wild type total heart cDNA and found a 50% reduction in its expression 
compared to wild type animals. As even minor reductions of expression of this gene result in 
severe bradycardia under normal conditions (Gloss et al., 2001), this was surprising, given 
that the TRα1+/m mice displayed only mild bradycardia (Tinnikov et al., 2002). 
Nevertheless, these results raise the possibility that the sympathetic drive in the TRα1+/m 
mutants is increased, masking the intrinsic defects in cardiomyocytes, discussed further in 
paper II and III.  
4.4 Interaction between Thyroid Hormones and the sympathetic system in regulation of the 
heart rate 
The interactions between thyroid hormone and sympathetic signaling have long been studied, 
as both hyperthyroidism and an excess of the sympathetic catecholamine ß-adrenaline induce 
tachycardia, forming the basis for treating hyperthyroid patients with sympatholytic 
agents/beta blockers to ameliorate changes in heart rate velocity. Surprisingly, however, 
neither plasma nor urine levels of catecholamines are increased in hyperthyroidism 
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(Coulombe et al., 1976), leading to the hypothesis that increased thyroid hormone levels 
result in sensitization to the sympathetic drive. However, analyses of human patients have 
shown that increased activity of the sympathetic system is also observed in long-term 
hypothyroidism (Cacciatori et al., 2000). Moreover, animal studies have reported that ß-
adrenergic receptors are up-regulated by TH (Hammond et al., 1987) and T3-bound TR has 
been shown to bind a TRE on the ß1-adrenergic receptor gene (Bahouth et al., 1997) causing 
a 4-fold increase of expression (Bahouth, 1991). Taken together, these data raise the 
possibility that the increased number of ß-adrenergic receptors could enhance the sympathetic 
sensitivity of the hyperthyroid heart. On the other hand, a recent study suggest that the effects 
of TH on the heart may be independent of ß-adrenergic signaling as effects of 
hyperthyroidism on the heart rate were similar between ß-adrenergic receptor KO and wild 
type mice (Bachman et al., 2004).  
4.5 Consequence of mutant TRα1 on the autonomic regulation of the heart (paper II) 
To better understand the interaction between these pathways, TRα1+/m mice were analyzed 
in paper II: we observed no difference in the mRNA levels of either ß-adrenergic receptor or 
parasympathetic muscarinic receptor levels as compared to wild type controls. Recent studies 
have demonstrated that TH centrally affects the autonomic control of peripheral tissues such 
as liver and brown adipose tissue (Klieverik et al., 2009; Lopez et al., 2010). However, upon 
injection, of freely moving TRα1+/m mice reared at room temperature, with either 
scopolamine, an inhibitor of parasympathetic signaling, or timolol, which blocks sympathetic 
signaling, no changes in the heart rate were observed relative to wild type controls, 
suggesting that the mutant TRα1 receptor does not affect the regulation of the heart rate by 
the ANS at room temperature. However, TRα1+/m mice fail to switch between the two 
branches of the ANS as indicated by the fact that the differences in heart rate became more 
pronounced following a stress stimulus or normal activity at night (paper II). Both of these 
conditions require a change of autonomic control for homeostasis (Dampney et al., 2008; 
Ikeda et al., 2007), raising the possibility that intact TRα1 signaling is required for ANS-
mediated central adjustment of heart rate to environmental changes. The murine heart is 
predominantly controlled by the sympathetic nervous system at room temperature (Walsh, 
1969), whereas at 30ºC it switches to parasympathetic control (Swoap et al., 2008). When the 
mice were reared at thermoneutrality, both genotypes displayed slower heart rate compared to 
those reared at room temperature. When injected with scopolamine, the heart rate in wild type 
mice remained increased after the initial stress response while the TRα1+/m heart rate was 
unaffected by the treatment. When injected with timolol, the heart rate of the TRα1+/m mice 
decreased dramatically, whereas the basal heart rate of the wild type mice remained 
unaffected, implicating that TRα1+/m mice failed to switch the autonomic control of the 
heart rate as they stayed on the sympathetic control even at thermoneutrality. As the ANS is 
regulated centrally (Saper, 2002), our results demonstrate that the mutation in TRα1 impairs 
the central adaptation of the cardiac control. 
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4.5.1 Consequence of mutant TRα1 on central regulation of cardiovascular functions (paper 
III) 
While recent studies have unraveled some of the molecular mechanisms of TH-mediated 
central regulation of peripheral tissues, little is known about the molecular mechanisms 
governing the central regulation of the heart rate. Paper III has helped to clarify this issue. In 
TRα1+/m mutants, we found a 70% reduction of parvalbumin positive (pv+) neurons in the 
anterior hypothalamic area (AHA) region of hypothalamus, the master regulator of the ANS 
(Saper, 2002). Reactivation of the mutant receptor failed to normalize the number of pv+ 
cells, indicating that intact TRα1 signaling is necessary for the development of these cells. 
This was further confirmed by the reduced number of pv+ neurons at P10 and P14 in the 
TRα1+/m mutants relative to wild type animals. Patch-clamp recordings of the AHA pv+ 
neurons revealed that all pv+ neurons tested responded to changes in temperature ranging 
from 25ºC to 40ºC. To determine their physiological role, pv+ cells were selectively ablated 
in wildtype mice expressing Cre recombinase in these cells, using diphtheria toxin, yielding 
40% reduction in cell number.  Heart rate measurements were taken from freely moving 
animals using radio telemetry transmitters, revealing slight tachycardia at room temperature 
in pv+ neuron-ablated animals, which became more pronounced at night as well as upon 
exposure to cold as compared to control animals. As the autonomic innervation of the heart 
shifts in rodents with changes in temperature and environment (Paper II), (Dampney et al., 
2008; Ikeda et al., 2007) we next tested whether the ablation of AHA pv+ neurons changes 
the autonomic control of the heart rate. Upon denervation of the heart with both scopolamine 
and timolol, reduced sympathetic and parasympathetic input to the heart was observed in 
mice with ablated AHA pv+ cells but not control animals, demonstrating the important role 
of these neurons in the autonomic control of cardiovascular function. 
4.5.2 Interaction between Thyroid Hormones and the systemic vascular system in regulation 
of the heart rate (paper III) 
Patients with hyperthyroidism have previously been shown to display increased systolic 
pressure and decreased systemic vascular resistance, which activates the renin-angiotensin-
aldosterone axis. Increased aldosterone promotes renal sodium resorption, increasing blood 
volume and hence cardiac output (Klein and Ojamaa, 2001). Hypothyroidism is characterized 
by an increase in both diastolic pressure and systemic vascular resistance, resulting in 
decreased blood volume (Kahaly and Dillmann, 2005). However, both conditions lead to 
hypertension but the mechanism underlying the changes in blood pressure and vascular 
resistance are unclear. 
Cardiovascular functions are regulated centrally through a complex interplay between 
hypothalamus, pituitary gland, adrenal gland and kidney. As lesions of the AHA cause a 
dramatic increase in blood pressure (Folkow et al., 1959), we assessed these parameters in the 
pv+ neuron-ablated animals and found hemodynamic changes, including increased systolic, 
diastolic and mean arterial pressure relative to the non-ablated controls, suggesting a role for 
these cells in the central regulation of blood pressure that could contribute to the 
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environment-dependent tachycardia observed in pv+ neuron-ablated animals (paper III). 
Ablation of these cells did not lead to changes in body weight, respiratory quotient or 
activation of brown adipose tissue as seen in the TRα1+/m mutants (Sjogren et al., 2007; 
Tinnikov et al., 2002) or changes in renin angiotensin system, suggesting that the AHA pv+ 
cells control cardiovascular function via the direct regulation of the autonomic nervous 
system, rather than through endocrine alterations. 
To test whether the hemodynamic changes were another aspect of the TRα1+/m animals, 
recapitulated by the ablation model, we next measured blood pressure and associated 
parameters in TRα1+/m mutants. Although we found that the renin-angiotensin-aldosterone 
axis components pulmonary Ace and serum angiotensin II were decreased in these mutants, 
blood pressure was surprisingly unchanged. As we believed that this defect was caused by 
peripheral actions of the mutant TRα1 on gene expression, we reactivated the receptor with 
supraphysiological doses of T3. Indeed, subsequent reactivation of the mutant receptor 
normalized Ace expression and angiotensin II levels, which was now accompanied by an 
increase in blood pressure parameters (systolic, diastolic and mean arterial pressure) as 
compared to T3-treated wild type controls, suggesting that the acute reactivation of the 
mutant receptor unmasked the underlying hypertension.  
4.5.3 Thyroid Hormone signaling and the central regulation of cardiovascular functions 
(paper II and III) 
TH has long been known to regulate cardiac function by direct gene regulation, 
hemodynamic changes, and via the ANS, but the mechanisms by which it regulated the latter 
two processes have remained enigmatic. In papers II and III, our research shows that TH 
signaling is required to integrate these processes and respond to environmental changes 
centrally, through the output of the previously unidentified pv+ neurons of the AHA (Figure 
5). We have identified at least 4 different subtypes of these cells, based on their response to 
temperature and TRH. The viral vector carrying pv promoter-driven diphtheria toxin targets 
all of these cells in the AHA, which makes it difficult to fully recapitulate the loss of these 
cells in TRα1+/m mice. It therefore remains unclear whether the full range of functions of 
these cells has been determined by these studies. Future experiments to better understand the 
development and identity of the individual subtypes, including the role of TRα1, should 
suggest routes to elucidate their functional roles. This could be done by e.g. Fluorescence-
activated cell sorting of mechanically dissociated anterior hypothalamic area from the 
TRα1+/m mutant and control Green Fluorescent Protein (GFP) mice (available in our lab) 
(Wallis et al., 2010), followed by RNA sequencing from single cells. Subsequent gene 
expression from major subpopulation could be analyzed in hypothalamic area from these 
mice.  
The mild but opposing heart rate defects seen at room temperature in the TRα1+/m mutants 
and pv+ neuron-ablated animals indicate that the tissue autonomous defect in TRα1+/m 
mutants i.e. the reduced HCN2 expression, has an overriding bradycardic effect on the altered 
autonomic cardiovascular regulation. Therefore, the central regulation of the cardiovascular 
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system and direct regulation of cardiac gene expression constitute a further integration of 
extrinsic and intrinsic regulatory mechanisms, counterbalancing the autonomic output of pv+ 
cells. Thus, TH/TRα1 signaling plays a key role in fine-tuning cardiovascular output, which 
is critical for robustness in response to environmental alterations. Whether the altered 
autonomic tone is due to an increase in the sympathetic tone remains to be determined. 
Further aspects of this role for TRα1 may include higher metabolic demand in these animals, 
which also would to lead to changes in the cardiac output. 
 
Figure 5. The heart receives several inputs, which lead to a changed heart rate. Firstly, the mutant 
TRα represses the Hcn2 gene expression in the SA node of the heart, leading to severe bradycardia. 
Secondly, pv+ neurons in the AHA integrate signals from the periphery, including temperature 
changes and blood pressure parameters, which modulates the central autonomic output and hence the 
heart rate.  
In summary, we have identified developmental hypothyroidism as a cause of hypertension 
due to permanent defects in brain development. Whether TH exerts a central control of 
cardiovascular functions in humans remains to be elucidated. Analysis of the angiotensin 
system and the cardiovascular responses to temperature in the recently identified patients 
with a mutation in TRα1 (Bochukova et al., 2012; Moran et al., 2013) should shed light on 
this issue. 
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5 EFFECTS OF A MUTANT THYROID HORMONE 
RECEPTOR ALPHA 1 ON OFFSPRING METABOLISM 
Disturbances in maternal TH signaling can affect the metabolic tone of the offspring and 
persists into adulthood. In paper IV, we investigate how maternal receptor-mediated 
hypothyroidism with consequent hypermetabolism and anxiety affects the metabolism and 
behavior of the offspring.  
5.1 In utero programming of offspring metabolism  
Research over recent decades has culminated in the birth of the field of developmental origins 
of health and disease (DOHaD) that strives to explain the epidemics of obesity, type 2 
diabetes and cardiovascular diseases. It has become clear that, in addition to the genetic 
predisposition of the embryo, maternal behavior during pregnancy contributes to the 
metabolic health outcome and adult phenotype of the embryo. Indeed, maternal nutrition and 
state of mind are critical regulators of fetal development, conveying information about the 
metabolic status of the mother, thereby allowing the embryo to adjust its metabolism to the 
world outside of the womb.  Astonishingly, it has been estimated that as much as 62% of the 
variation in human birth weight results from the intrauterine environment, compared with 
20% and 18% from maternal and paternal genes respectively (Holt, 2002).  
An association between environmental factors, e.g. nutrition, and cardiovascular disease later 
in life was first observed 80 years ago (Kermack et al., 1934). Records of children conceived 
during the 6 month long Dutch famine of 1944-45 indicate that babies born to nutrient-
restricted mothers had low birth weight and were more likely to develop obesity, type 2 
diabetes and cardiovascular disease later in life (Ravelli et al., 1976). These human 
observations prompted several animal studies that mimic such conditions, which showed that 
nutrient restriction, both in terms of caloric restriction or protein reduction, lead to different 
outcomes in adulthood, depending on which developmental stage the event occurred, as well 
as the nutrient supply postnatally. For example, caloric restriction exclusively during the 
prenatal period leads to obesity and insulin resistance in adult animals, whereas normal 
postnatal weight follows when it occurs during both the prenatal and lactation periods 
(McMillen and Robinson, 2005). Likewise, children conceived to nutrient-restricted mothers 
during the 1941-1944 Siege of Leningrad exhibited reduced birth weight that was not 
correlated to metabolic phenotypes such as obesity, glucose intolerance or cardiovascular 
disease in adulthood (Stanner et al., 1997). The negative outcomes observed in the Dutch 
cohort are due to rapid catch up growth during the childhood, made possible because of an 
abundant nutrient supply immediately after the war (McMillen and Robinson, 2005) as will 
be discussed in detail below. 
Many research groups have hypothesized about the mechanisms by which early life events 
shape the adult phenotype. In 1962, Neel suggested that “thrifty” genes were evolutionarily 
selected during periods when food was scarce, leading to improved capacity to store fat when 
food was plentiful and consequently to enhanced fitness of the individual. With food 
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abundant in the West today, this would place a substantial proportion of the population at 
high risk of developing obesity and insulin resistance (Neel, 1962). However, due to a lack of 
genes correlated with metabolic disorders, it became clear that a thrifty genotype would not 
be sufficient to explain the alarming epidemic of these disorders today (Gluckman et al., 
2007). In 1992, Barker and Hales proposed the thrifty phenotype hypothesis, in which factors 
in the womb determine the development of the embryo. Thus, poor intrauterine conditions 
stimulate the developing embryo to optimize the use of existing nutrients in order to ensure 
growth and survival (Hales and Barker, 1992). This could be achieved through blood flow 
and nutrient redistribution to favor the brain at the expense of e.g. liver, pancreas and muscle 
and/or through changes in the production of fetal and placental hormones that act as fetal 
growth programming factors (Barker, 2002). Others proposed “fetal programming” (also 
known as metabolic plasticity) to define an adaptive response of the embryo to ensure 
survival and postnatal growth, in which a given genotype is likely to give rise to different 
phenotypes depending on the environmental factors. Thus, if there is a mismatch between 
fetal and postnatal environment, the individual would be placed at risk for disease later in life 
as seen in those conceived during the Dutch famine (Gluckman et al., 2007).  
While the precise mechanisms remain unclear, the current view is that fetal programming is 
an adaptive process that occurs (1) through epigenetic regulation of genes during critical 
developmental windows, namely when tissues are in their proliferative and/or differentiating 
phases; and (2) by the coordinated action of glucocorticoids (GC), IGF-1, IGF-2, insulin, 
thyroid hormones (TH), and leptin (Fowden, 1995) which directly regulate either gene 
expression and/or the production of growth factors and other hormones by feto-placental 
tissues (Fowden and Forhead, 2004).  
Several reports support the thrifty phenotype and fetal programming hypotheses. For 
example, severe intrauterine conditions in the mother and consequent decreased energy 
supply across the placenta can lead to loss of structural units such as nephrons, hepatocytes, 
cardiomyocytes and pancreatic beta cells in the offspring (McMillen and Robinson, 2005), 
leading to life-long changes in function and structure of these tissues. For example, in rats, 
maternal starvation during four last days of the pregnancy led to 15% reduction in liver 
weight. The authors found that restricted nutrient availability in utero signals to hepatocytes 
to regulate the cell cycle, reducing proliferation and hence liver mass in the offspring 
(Gruppuso et al., 2005). Another study found that low-protein diet in mice leads to epigenetic 
silencing of hepatocyte nuclear factor 4a (Hnf4a), a regulator of islet beta cell transcription, 
and this leads to impaired beta cell differentiation and consequently altered glucose 
homeostasis (Sandovici et al., 2011).  
5.2 Programming by in utero factors 
The main roles of the placenta are to supply nutrients and oxygen to the developing embryo 
and to produce hormones and growth factors to support the embryo. Several factors, such as 
glucose, thyroid hormones, leptin and glucocorticoids, can cross the placenta, whereas others, 
e.g. insulin, are expressed by the placenta itself and reflect the metabolic status of the mother 
  21 
(Hiden et al., 2009). Malnutrition leads to reduced oxygen delivery capacity of the placenta. 
In addition, the size of the placenta is dependent on the nutrient supply, and its size is a 
determining factor in the amount of glucose that can be transferred to the embryo, with 
obvious implications for fetal programming (Coan et al., 2008).  
Glucocorticoids (GC) are the best example of an in utero factor that can easily pass the 
placenta and program the embryo. Studies have shown that the HPA axis can be prenatally 
programmed by malnutrition in the form of caloric restriction or low protein diet, as well as 
maternal stress, which leads to elevated GC concentration in the offspring (McMillen and 
Robinson, 2005; Welberg and Seckl, 2001). Administration of GC during the critical 
developmental window results in impaired renal development, hypertension, glucose 
intolerance and insulin resistance (Gicquel et al., 2008). For example, in rats, daily treatment 
with synthetic GC during the final week of gestation results in elevated basal plasma 
corticosterone levels in those offspring as adults (Welberg and Seckl, 2001) leading to 
increased blood pressure and obesity (Rosmond and Bjorntorp, 2000). Prenatal exposure to 
GC also alters glucocorticoid receptor (GR) gene expression in adult tissues such as liver, 
hypothalamus and hippocampus (Fowden and Forhead, 2004; Weaver et al., 2004), causing 
further alterations to the HPA axis in adulthood. Moreover, it induces changes in placental 
GLUT gene expression, which may alter transplacental glucose transport to the fetus and with 
it fetal metabolism and growth (Hahn et al., 1999). Taken together, GCs exert their functions 
through the altered gene expression of receptors, enzymes, growth factors, transcription 
factors, ion channels, and transporters in the embryo, altering hormone levels of the fetal 
programming factors such as IGF1/2 and T3, respectively. Ultimately, these perturbations 
lead to altered proliferation, differentiation, and tissue growth (de Moura and Passos, 2005). 
5.3 Programming by epigenetic mechanisms 
In utero factors can directly act on genes through epigenetic mechanisms, which result in 
changes in gene expression without altering the actual DNA sequence. Such modifications 
are essential for proper development, as they regulate gene expression in a tissue-specific 
manner. There are three major classes of epigenetic modifications: DNA methylation, histone 
modifications and non-coding RNAs. Genes that are required later in development are 
typically silenced by histone modifications that can be easily reversed once the genes need to 
be turned on again. Long-term silencing, on the other hand, is largely based on DNA 
methylation and is enriched at centromeres and transposable elements that have been 
incorporated into the DNA over the course of evolution. Moreover, this process regulates 
female X chromosome inactivation and imprinted genes. However, besides these events, it 
has become clear that certain genes can be subjected to altered DNA methylation by 
environmental factors, such as stress or nutrition, leading to an altered phenotype. Sometimes 
these traits can even be inherited across several generations (Anway et al., 2005). As paper 
IV of the thesis concerns a change in DNA methylation, I will mostly focus on this class of 
modification. 
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Epigenetic modifications are erased across the genome twice in an animal’s life cycle: firstly 
at the time of gametogenesis and secondly during the pre-implantation period of embryonic 
development. Primordial germ cells (PGCs) give rise to gametes, and their genomes undergo 
DNA de-methylation, including at imprinted genes at E10.5-E11.5, followed by de novo 
methylation and re-acquisition of imprints. This latter process continues up to E18.5 in males, 
while in female maturing oocytes, it ends immediately before ovulation in females. The 
second round of epigenetic reprogramming is initiated by fertilization and occurs during the 
pre-implantation period at which time all modifications with the exception of those at 
imprinted genes are removed (Reik, 2007).  
DNA methylation is associated with gene silencing, as it often occurs in the promoter or 
enhancer regions of genes. In mammals, methylation occurs in most cases at cytosine 
nucleotides that are followed by guanine nucleotides: so-called CpG islands. De novo 
methylation, in which a methyl group is added to the 5-carbon of cytosine by enzymes called 
DNA methyltransferases (DNMTs), is introduced during gametogenesis by DNMT3A and is 
maintained between the mitotic division by DNMT1s in embryonic and adult tissues. De-
methylation occurs by both passive and active mechanisms: in the former, when a new DNA 
strand is synthesized during replication, the methylation pattern is reestablished by DNMT1, 
whereas the latter occurs during the pre-implantation period by removal of all methyl groups. 
Recent studies have identified the TET family of enzymes as capable of disrupting such 
highly stable carbon-carbon bonds. These studies have shown that TET enzymes oxidize 5- 
methylcytosine to form 5-hydroxymethylcytosine, which is then actively reverted to cytosine 
through iterative oxidation and thymine DNA- mediated base excision repair (He et al., 2011; 
Ito et al., 2011). 
Methylation silences genes by either changing transcription factor binding of DNA and/or by 
attracting methyl-CpG-binding domain proteins (MBDs) that in turn recruit chromatin-
remodeling proteins, resulting in heterochromatin formation, i.e. chromatin compaction. 
Histones, the main proteins that make up chromatin, are positively charged and associate with 
the negatively charged DNA to form nucleosomes. Each nucleosome contains DNA wrapped 
around four pairs of histone proteins called H2A, H2B, H3 and H4. The tails of nucleosomes 
are subjected to covalent modifications that will either lead to stronger DNA binding 
(compaction) and hence transcriptional repression, or to looser DNA binding and increased 
accessibility to the transcriptional machinery. These modifications include lysine acetylation, 
lysine and arginine methylation, serine and threonine phosphorylation, and lysine 
ubiquitination and sumoylation (Vaquero et al., 2003). Histones are regulated by a set of 
enzymes that will add or remove these modifications, including histone acetyltransferases 
(HATs), hitone deacetylases (HDACs), histone methyltransferases (HMTs) and histone 
demethylases (HDMs). Epigenetic regulation can also be influenced by RNA interference, 
that is the presence of non-protein coding RNAs that can interfere with gene expression 
through interaction with RNA, DNA or chromatin.  
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5.3.1 Crosstalk between metabolism and epigenetics 
The activity of many DNA- and histone-modifying enzymes is dependent on a cell’s 
metabolic status. For example, DNMTs and HMTs both transfer a methyl group from S-
adenosyl methionine (SAM) to the substrate. As SAM is derived from the essential amino 
acid methionine, it is possible to alter its levels through the diet (Poirier et al., 2001). Dietary 
intake of methyl donors such as folate is linked lo levels of DNA methylation. In the Agouti 
mouse model (Wolff et al., 1998) it has been shown that maternal methyl group providing 
supplements increased DNA methylation, and this was correlated with a reversion to brown 
coat color and decreased future development of obesity and insulin resistance. Moreover, it 
has been shown that glutathione depletion leads to genome-wide DNA hypomethylation due 
to depletion of methionine pools (Lertratanangkoon et al., 1997) and it has been suggested 
that a poor intrauterine environment leads to oxidative stress, possibly due to reduced oxygen 
transfer through the placenta, which is known to reduce glutathione levels (Pham et al., 
2003). A third example is the protein-restricted diet rat model. Adult offspring of these rats 
develop high blood pressure and cardiovascular disease (Watkins et al., 2008), and exhibit 
increased expression of GR and PPARα in the liver. It was shown that this increase correlates 
with decreased promoter methylation, probably due to lack of essential amino acids. TET 
activity is also thought to depend on the metabolic status of the cell. These enzymes depend 
on α-ketoglutarate (αKG) to oxidize 5-methylcytosine to 5-hydroxymethylcytosine. αKG is 
the key metabolite of the TCA cycle and can be derived either from glucose or glutamine (Lu 
and Thompson, 2012). Other examples that connect metabolism to epigenetics are 
summarized in Figure 6. 
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Figure 6. Glucose entry through the glycolysis determines the NAD+/NADH ratio, which regulates 
Sirt1 activity. TCA cycle intermediates, citrate and aKG, are exported out of mitochondria. Citrate is 
converted to acetyl-CoA which is used as a donor for HAT-mediated histone acetylation. TET and 
JHDM use aKG as a cofactor for DNA demethylation reactions. The essential amino acid Methionine 
synthesize SAM, which is then used as substrate for HMT and DNMT. Lastly, a low ATP/AMP ratio 
can activate AMPK, which can phosphorylate histones. NAD, Nicotinamide adenine dinucleotide; 
Sirt, sirtuin histone deacetylase; TCA, citric acid cycle; αKG, α-ketoglutarate; Acetyl-CoA, acetyl 
coenzyme A; HAT, histone acetyltransferase; TET, Ten-eleven translocation methylcytosine 
dioxygenase; JHDM, Jumonji Domain-containing Histone Demethylase; SAM, S-Adenosyl 
methionine; HMT, histone methyltransferase; DNMT, DNA methyltransferase; ATP, adenosine 
triphosphate; AMP, adenosine monophosphate; AMPK, AMP-activated protein kinase A.  
5.3.2 Epigenetic inheritance 
Importantly, epigenetic marks that are established throughout the postnatal lifespan of the 
organism will not be transmitted to the next generation unless they are established in the 
gametes. In order for an epigenetic mark to be transferred to the next generation, it must arise 
during gonadal development and resist epigenetic reprogramming. Though there is some 
evidence that this occurs in mice, little is known about epigenetic inheritance in humans. 
Lumley and colleagues reported that children born to mothers during the Dutch famine were 
smaller than average and that this effect could last two generations (Lumey, 1992); however, 
same authors failed to find the same connections to these findings (Stein and Lumey, 2000). 
Using a mouse model to mimic the Dutch famine, reduced birth weight, glucose intolerance 
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and obesity were observed in both first and the second generations (Jimenez-Chillaron et al., 
2009). However, only embryo transfer experiments to non-exposed dams would exclude 
effects of the in utero environment and show that the epigenetic information is inherited via 
the gametes.  
There are several studies using animal models that report trans-generational inheritance, in 
some cases up to the fourth generation (F4). For example, pregnant rats that were exposed to 
the endocrine disruptor vinclozolin during the period of gonadal sex determination induced a 
phenotype in the adult F1 males, which included decreased viability and cell number in the 
sperm and higher infertility. This was correlated to altered DNA methylation persisting to F4 
by paternal transmission (Anway et al., 2005).  
The most frequently cited example of epigenetic inheritance through the gametes is the 
Agouty viable yellow Avy allele that arose as a result of intracistenal A particle (IAP) 
insertion upstream of the Agouty locus. Expression of agouti protein is directed by promoter 
elements in retro-transposons and leads to yellow fur, obesity, diabetes and increased 
susceptibility to tumors. The DNA methylation status of the promoter is correlated to 
transcriptional activity and the mice carrying the allele display coat colors raging from yellow 
to pseudoagouti (brown). Trans-generational inheritance was only seen through the female 
line as yellow dams produce a high percentage of yellow offspring, which was not observed 
when Avy was transmitted through the paternal line. Embryo-transfer showed that the 
phenotype was transferred through gametes, as surrogates still produced a higher percentage 
of yellow dams (Morgan et al., 1999). Another well-known example of gametal trans-
generational inheritance is the Axin fused allele (AxinFu), which also contains an IAP element 
that, depending on the methylation status within the transposon, influences expression of 
linked genes, and results in a kinked tail phenotype. It was shown that the epigenetic state at 
AxinFu was inherited trans-generationally by both maternal and paternal transmission 
(Rakyan et al., 2003).  
However, none of the aforementioned studies proposed a mechanism by which such 
epigenetic marks could be inherited, one study even arguing that DNA methylation was not 
the inherited mark responsible for the phenotype in the Agouty mice (Blewitt et al., 2006), 
despite reports showing that IAPs are resistant to reprogramming (Lane et al., 2003). It has 
been hypothesized that chromosome modifications promoting DNA methylation, RNA-based 
mechanisms in the sperm, or factors in the semen or some diffusible factor in the egg 
cytoplasm damns may be responsible (Daxinger and Whitelaw, 2012).  
Caution should be exercised when interpreting data to determine whether trans-generational 
inheritance through gametes occurs. For example, rats nurtured by stressed mothers are more 
likely to become stressed, and this phenotype is transmitted across generations. Stressed 
rodent mothers fail to adequately care for their offspring, changing the serotonin drive to the 
hippocampus of the offspring. This in turn leads to altered release of a transcription factor 
that binds the promoter of GR, stimulating DNA methylation and histone acetylation, and 
consequently leading to altered GR expression and HHPA axis tone that persists into the 
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adult life of the offspring (Francis et al., 1999). It is therefore not surprising that the offspring 
exhibit the same behavior to which they were exposed, thus perpetuating the phenotype 
across generations. This is en example of trans-generational inheritance that does not occur 
through the gametes but through an adaptive response linked to an epigenetic change that 
theoretically better equips the offspring to meet the stressful life outside the womb. In order 
to consider epigenetic inheritance through the gametes, it is not sufficient to only analyze the 
phenotype in F2 generation: if the pregnant mother (F0) is exposed during the gonadal 
development of the offspring (F1), then an epigenetic phenotype will also be observed in F2 
without further exposure; however, if F3 shows the trait, gametal transmission should be 
considered.  
5.4 Sexual dimorphism in metabolism and behavior 
Metabolic differences in lipid profiles have been observed between men and women 
conceived during the Dutch famine. Middle-aged daughters showed elevated cholesterol 
concentrations and triglyceride content, which was not observed in middle-aged sons (Lumey 
et al., 2009). By contrast, studies on intrauterine growth restriction in rats showed that males 
were more prone to hypertension as compared to female offspring (Grigore et al., 2008). 
Moreover, maternal exposure to stress puts males at greater risk of neurodevelopmental 
disorders such as autism and schizophrenia (Gabory et al., 2013). This could be explained by 
the finding that stress in early pregnancy leads to sex-dependent effects on placental gene 
expression, modifying the fetal transport of key growth factors and nutrients. For example, 
glucocorticoids indirectly increase expression of insulin-like growth factor binding protein 1 
(IGFBP-1) (Degenhardt et al., 2006) which is known to down-regulate genes involved in fetal 
growth (Kajimura et al., 2005). As reductions in growth factors during critical developmental 
periods have been linked to affective and neurodevelopmental disorders, the decrease in 
available growth factors may play a role in male fetal programming. However, while this 
example outlines how altered placental gene expression could affect a fetus, it does not 
explain how only male placentas are affected in the first place, which has yet to be elucidated. 
Converging lines of evidence suggest that sex differences in metabolic and behavioral 
phenotypes originate early in development, in particular in the placenta. Many placental 
genes display different epigenetic marks that reflect the gender of the embryo and respond 
differently to the nutrient supply. For example, embryonic female placenta of pregnant mice 
fed either high fat, low fat or intermediate diet showed drastic differences in gene expression 
as compared to male placenta in response to each maternal diet (Mao et al., 2010). This is 
consistent with the finding that high- fat diet induces hypomethylation only in female 
placentas at E15.5 (Gabory et al., 2013), clearly indicating sexual dimorphism of the 
placental tissue, suggesting that female placentas are more sensitive to nutritional fluctuations 
than the male counterparts.  
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5.5 Consequence of a mutant TRα1 on offspring metabolism (paper IV) 
As described in section 1.3.1, TRα1+/m mutants represent a novel model of receptor 
mediated maternal hypothyroidism, and are very relevant for the study of such effects on 
offspring metabolism and behavior due to the recent finding of a human female patient with a 
similar mutation (Moran et al., 2013). As serum corticosterone levels are unchanged in these 
animals (Paper IV), we wanted to investigate how these events would program the 
developing embryo on the molecular level.  
5.5.1 Mh mice unexpectedly exhibit a favorable metabolic outcome 
In paper IV, we show that male but not female wild type mice (mh mice) born to mutant 
TRα1+/m mothers weigh less, display reduced body fat mass and increased lean mass. Their 
glycogen levels are decreased by 60%, accompanied by accelerated glucose clearance and 
increased oxygen consumption, while food intake remained normal. On the molecular level, 
we found decreased liver expression of Mgll, the enzyme responsible for metabolizing the 
cannabinoid receptor ligand arachidonyl glycerol (2-AG), which was associated with 
hypermethylation of a specific CpG site in the Mgll promoter region. Mgll expression was 
also decreased in gastrocnemius muscle. Interestingly, we observed a modest decrease in 
cannabinoid 1 receptor (CB1R) expression in the hypothalamus of the mh mice. As 
cannabinoids have been shown to be involved in mechanisms of behavioral reward (Keeney 
et al., 2008), we placed running wheels in the cages and observed an increase in running 
wheel behavior in male mh mice but not females. Thus, although these animals have an 
apparently favorable metabolic phenotype, the desire to run more intensively might reflect a 
mental disorder that is reminiscent of addiction or ADHD. 
5.5.2 Mh mice as a possible model for mental disorders? 
It has been shown that running wheel behavior is highly rewarding and hence addictive, even 
to such extent that mice are willing to cross an aversive water barrier to receive wheel-
running reward (Keeney et al., 2008). High runner (HR) mice, which are selectively bred for 
this behavior, resemble the mh mice in terms of both metabolic and wheel running 
phenotypes. When HR mice are denied running, they show differential neuronal activity, as 
indicated by cFos, in several brain regions involved in arousal (lateral hypothalamus), natural 
reward (medial frontal cortex) and initiation of locomotion (caudate putamen) (Rhodes et al., 
2003). Interestingly, CB1R is expressed in all these regions (Cota et al., 2003; Lisboa et al., 
2010; Mailleux and Vanderhaeghen, 1993) and administration of rimonabant, a CB1R 
receptor antagonist, decreased wheel running in HR mice (Keeney et al., 2008). Therefore, it 
would be interesting to perform these experiments in mh mice to assess the role for CB1R in 
the mh phenotype, thus linking the maternal in utero environment to addiction.  
Addiction is neurologically similar to ADHD, and the two conditions often coincide (Kaye et 
al., 2014), raising the possibility that an ADHD like disorder causes the running wheel 
phenotype in mh mice. Indeed, administration of Ritalin, a pharmacological agent for ADHD 
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treatment, has also been shown to decrease wheel running in HR mice (Rhodes et al., 2005). 
Ritalin inhibits the dopamine transporter, and the dopamine system is a critical component of 
reward behavior. ADHD is a complex disorder, with few genes directly implicated; however, 
fetal programming can play a role, as obesity among pregnant women has been associated 
with 2.8-fold increase in prevalence of ADHD in children (Buss et al., 2012). Moreover, in 
another similarity with the mh phenotype, ADHD is sexually dimorphic, with men more 
susceptible than women (Biederman et al., 2008). Whether defective dopamine or 
endocannabinoid signaling however underlies the phenotype of mh male mice remains yet to 
be established. 
As proper brain development depends on an interplay between the individual´s genotype and 
conditions during early development (McMillen and Robinson, 2005) one might hypothesize 
that the in utero environment of TRα1+/m dams leads to altered susceptibility to 
psychological disorders such as addiction and/or ADHD, and it will be interesting to test this 
possibility. A complex interplay between peripheral organs and the central nervous system, 
particularly the hypothalamus, has been shown to regulate numerous physiological processes 
(paper III), (Yadav et al., 2009). The extent to which such mechanisms underlie the 
phenotype of the mh mice is an open question, but it would be interesting to explore the 
potential for a link between the decreased expression of liver and muscle Mgll and the 
decreased CB1R expression in the hypothalamus.  
5.5.3 Potential factors that could cause the phenotype  
Since the available blood glucose in the circulation of hypermetabolic TRα1+/m dams to a 
large extent serves to replenish BAT energy stores (Sjogren et al., 2007), it is reasonable to 
speculate that reduced glucose could be transferred to the embryo. As summarized in figure 
X, lower glucose transfer can lead to decreased levels of NAD+/NADH and aKG that could 
potentially change the methylation patterns of the genes in somatic tissues or developing 
gametes, resulting in hypermethylation of the Mgll promoter. Although this should be tested 
by treating mutant dams with glucose or T3 throughout the pregnancy and lactation period, as 
mutant dams are euglycemic under normal conditions (Sjogren et al., 2007), other factors are 
more likely to contribute to the phenotype.  
Leptin has been proposed to act as a programming factor (de Moura and Passos, 2005). As 
reduced fat depots in mutant dams lead to decreased circulating leptin levels (Sjogren et al., 
2007), one could hypothesize that decreased leptin availability through the placenta could 
contribute to the mh phenotype. However, low leptin levels during gestation or lactation leads 
to obesity in the offspring, which is not observed in the mh mice. However, as mh mice are 
exposed to similar conditions during lactation as in utero, cross-fostering to wild-type 
mothers would provide new clues.  
Although TRα1+/m mice display high levels of anxiety (Venero et al., 2005), corticosterone 
levels in TRα1+/m dams were normal under standard conditions, hence it is not known which 
factor produced by this physiological condition could lead to the phenotype observed in the 
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mh mice. Maternal depression is one of the most common prenatal complications in women 
(Sandman et al., 2014), and the pregnancy itself could have induced several additional 
anxiety-related symptoms that would alter glucocorticoid levels in the TRα1+/m mutant dams 
and consequently affect the embryo. Thus it would be interesting to test corticosterone levels 
and anxiety phenotype in pregnant TRα1+/m dams.  
Hypothalamus is the master regulator of metabolism that integrates CNS and peripheral 
tissues and could act as a source for fetal programming factors. Gene expression profiling of 
hypothalamus from mutant females and possibly pregnant mutant females could lead to novel 
insights. Given the importance of fetal programming by the placenta, gene expression 
profiling of the placentas from mh male and female embryos versus wild-type male and 
female embryos should be analyzed in order to provide new clues to different responses to the 
in utero environment. Furthermore, to test whether the phenotype is transferred through the 
gametes, F3 male generation should also be analyzed.   
It seems unlikely that the phenotype is caused by fluctuation in maternal nutrient supply, as 
female offspring do not display a metabolic phenotype and evidence suggest that females are 
also highly responsive to any metabolic disturbances that happen during the fetal 
development. Mechanisms directing sexual dimorphism are at work during organogenesis, 
and it has been shown that chromatin structures and epigenetic marks differ between males 
and females in the brain and liver, two tissues, which show a striking phenotype in mh mice. 
Besides epigenetic differences between the sexes, anatomical differences have been observed 
between male and female brains, notably in the hypothalamus and cortex (Ngun et al., 2011), 
and sexual dimorphism has also been observed in the behavioral and neurochemical 
responses to cannabinoid signaling (Rubino and Parolaro, 2011). These findings raise the 
possibility that the reason for differences between mh male and female mice might be due to 
distinct responses to an adaptation that was made during fetal life. 
Genome-wide association studies have been inadequate in finding genetic contributions to 
several current health problems such as obesity, diabetes, or cardiovascular disorders. 
Therefore the current view is that other processes, such as in utero factors and epigenetic 
mechanisms are involved. However, little is known how these work on a molecular level. 
Endocrine disorders play a big role in this and can largely be caused by endocrine disruptors 
that we are exposed to daily as they can be found in our food, food containers, clothes, 
medical equipment or toys. Some of the well-known compounds that are still in use or have 
just been banned include bisphenol A, phthalates and parabens. Therefore it is paramount to 
study the consequences of maternal endocrine problems on the offspring. In this study we 
have focused on effects of hypothyroidism and more specifically on TRα1 mediated 
hypothyroidism, which is specially important today as recently identified TRα1 mutations in 
humans were found to be compatible with life and even reproduction. Here we provide 
insights to how the children of such mothers could be affected, even if they don’t inherit the 
maternal TRα1 mutation. Moreover, the study could help finding molecular links for 
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addiction and ADHD like phenotype, which are other unsolved problems likely caused by 
epigenetic variables. 
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6 SUMMARY 
The research conducted in this thesis has provided novel insights into roles of THs during 
development in programming of cardiovascular and metabolic functions as well as behavior. 
We show that THs program hepatic glycogen stores, which is of high relevance throughout 
postnatal life, as hepatic glycogen serves to maintain normal glucose levels. We also show 
that TH signaling affects peripheral and central mechanisms controlling cardiovascular 
functions, for instance through the developmental regulation of recently identified cell type in 
the hypothalamus, which alters autonomic output in response to environmental changes. 
Lastly, we show that maternal TH signaling modulates central and peripheral metabolic and 
behavioral pathways in the offspring through epigenetic regulation of gene expression. Our 
findings contribute to a better understanding of thyroid hormone action in development, and 
are of immediate clinical relevance, as they support the diagnosis and the treatment of 
patients with a mutation in TRα1, which were recently identified.  
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divnu hranu i dobra vina. Jedva cekam da vas vidim sve! Dunja: My dear sweet cousin who 
is always following her dreams and not scared of taking new directions. You are really 
awesome! Vesna: Din styrka är imponerande! Önskar vi kunde ses oftare. Goga: Min 
modiga coola kusin som vågar bryta normer och är ärlig mot sig själv. Du har alltid inspirerat 
mig med ditt hårda arbete och förmågan att komma över svåra situationer, både privat och 
under studietiden. Är så glad att du har tackat ja till Gudmor rollen J Nela: full of energy, 
wonderful, crazy, inspiring, clever, brave, absolutely gorgeous, so much fun to be 
around…attributes are endless to describe you…one just has to know you. You never cease 
to surprise and your life is a real adventure. I totally dig you! Milan: Moj striko i madionicar! 
Da nije bilo tebe u pravo vrijeme ko zna da li bi ikad uzela ovaj put. Hvala ti sto si uvijek bio 
uz mene! Ti si jedna velika inspiracija jer znas kako da ostvaris svoje snove. Veselim se 
budicih vecera i fika sa tobom i dragom Beom. Ana: Moja draga seka koja je uvijek tako 
pazljiva i misli na sve nas. Volim te puno! 
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My parents: Ne znam ni gdje da pocnem.. Ljubav i divljenje koje osjecam prema vama je ne 
opisivo. Kroz toliko toga smo zajedno prosli i cesto u teskim situacijama pomislim na vas i 
kako ste se borili i kako ste fantasticno jaki ljudi. Vi ste moja najveca inspiracija u zivotu i ne 
mogu zamisliti bolje roditelje. U svakom trenutku ste bili uz mene i znali mi pokazat pravi 
put, cak i da mi pomognete izabrat fakultet. Taso moj, dao si mi puno tvojih dobrih strana i 
vrlo sam ponosna sa tim. Mamo moja, ostajes mi najbolja prijateljica i nadam se da Sophie i 
ja mozemo imat vezu kao sto je nasa.   
My family 
Till min ofödda son: Jag längtar så mycket efter dig!  
Sophie: Du har gett mig så mycket glädje och lycka. Mitt liv har fått en djupare mening.  
Chris: I can´t believe I was so lucky in life to find you. You are everything to me! 
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